Sale!

MYD88 Gene Mutation Analysis Test Cost

Original price was: 2,400 د.إ.Current price is: 1,800 د.إ.

-25%

The MYD88 Gene Mutation Analysis Test is a specialized diagnostic procedure aimed at identifying mutations within the MYD88 gene, a critical component in the immune response and signaling pathways within cells. This test is particularly relevant for patients suspected of having conditions that are linked to MYD88 mutations, such as certain types of lymphomas and other hematological malignancies. By analyzing the genetic material extracted from a patient’s blood or tissue sample, this test can pinpoint specific alterations in the MYD88 gene that may contribute to disease pathogenesis or influence treatment strategies.

Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the MYD88 Gene Mutation Analysis Test is priced at 1800 AED. This cost reflects the comprehensive nature of the analysis, including the sophisticated technology and expert interpretation involved in identifying and understanding the implications of MYD88 gene mutations. For patients and healthcare providers, the results of this test can be invaluable in guiding clinical decisions, tailoring personalized treatment plans, and ultimately improving patient outcomes.

Description

MYD88 gene Mutation Analysis Test

Test Name: MYD88 gene Mutation Analysis Test

Components: EDTA Vacutainer (2ml)/Paraffin embedded tissue blocks

Price: 1800.0 AED

Sample Condition: Peripheral blood/Tumor tissue

Report Delivery: 5-7 days

Method: Sanger Sequencing

Test Type: Genetics

Doctor: Gynecologist

Test Department:

Pre Test Information: MYD88 gene Mutation Analysis can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

MYD88 gene mutation analysis is a diagnostic test that is used to identify mutations in the MYD88 gene. The MYD88 gene provides instructions for making a protein called myeloid differentiation primary response 88, which is involved in the immune response. Mutations in the MYD88 gene have been associated with various diseases, including certain types of cancer and autoimmune disorders.

The most common mutation in the MYD88 gene is known as L265P, and it has been found in a subset of patients with lymphoma and multiple myeloma. The analysis of MYD88 gene mutations typically involves sequencing the DNA of the gene to identify any changes or alterations in the genetic code. This can be done using various techniques, such as Sanger sequencing or next-generation sequencing.

The results of MYD88 gene mutation analysis can help in the diagnosis and management of patients with suspected genetic disorders or certain types of cancer. For example, the presence of the L265P mutation in the MYD88 gene can help differentiate between different types of lymphoma and guide treatment decisions.

Overall, MYD88 gene mutation analysis plays an important role in personalized medicine by providing valuable information about the genetic makeup of individuals and helping to tailor treatment strategies based on their specific genetic profile.

Test Name	MYD88 gene Mutation Analysis Test
Components	EDTA Vacutainer (2ml)/Paraffin embedded tissue blocks
Price	1800.0 AED
Sample Condition	Peripheral blood\/Tumor tissue
Report Delivery	5-7 days
Method	Sanger Sequencing
Test type	Genetics
Doctor	Gynecologist
Test Department:
Pre Test Information	MYD88 gene Mutation Analysis can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	MYD88 gene mutation analysis is a diagnostic test that is used to identify mutations in the MYD88 gene. The MYD88 gene provides instructions for making a protein called myeloid differentiation primary response 88, which is involved in the immune response. Mutations in the MYD88 gene have been associated with various diseases, including certain types of cancer and autoimmune disorders. The most common mutation in the MYD88 gene is known as L265P, and it has been found in a subset of patients with lymphoma and multiple myeloma. The analysis of MYD88 gene mutations typically involves sequencing the DNA of the gene to identify any changes or alterations in the genetic code. This can be done using various techniques, such as Sanger sequencing or next-generation sequencing. The results of MYD88 gene mutation analysis can help in the diagnosis and management of patients with suspected genetic disorders or certain types of cancer. For example, the presence of the L265P mutation in the MYD88 gene can help differentiate between different types of lymphoma and guide treatment decisions. Overall, MYD88 gene mutation analysis plays an important role in personalized medicine by providing valuable information about the genetic makeup of individuals and helping to tailor treatment strategies based on their specific genetic profile.